Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Sep 22, 2016 12:00pm
183 Views
Post# 25265793

RE:Tobira Therapeutics

RE:Tobira TherapeuticsThank you everyone for your thoughts & ideas re. Tobira's liver fibrosis drug versus Prometic's fibrosis drugs. I am a very long term PLI investor and do belive in the products PLI are developing.  I guess the question I am asking the board is why didn't Allergen try to take us over versus Tobira?? I wish the doctor (can't remember his name ) would comment or better a comment from Fred.  I guess that's wishful thinking?? 
Bullboard Posts